Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

New Royalty Partner

16 Feb 2021 07:00

RNS Number : 1749P
Duke Royalty Limited
16 February 2021
Β 

Β 

16 February 2021

Β 

Duke Royalty Limited

Β 

("Duke Royalty", "Duke" or the "Company")

Β 

New Royalty Agreement with a Leading UK Steel Fabrication Business

Β 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has further diversified its revenue base by entering into a Β£6.2 million royalty financing agreement (the "Financing") with Meteor HoldCo Limited, which undertakes business as Fabrikat (Nottingham) Limited ("Fabrikat"). Formed in 1985 and based in Sutton-in-Ashfield, UK, Fabrikat is a fabricator of steel products supplying the UK street lighting and guardrail markets.

Β 

Highlights:

Β 

Β· Initial cash yield of approximately 14% per annum via monthly payments, which commence immediately

Β· 30-year secured financing, with distributions to be adjusted annually to reflect Fabrikat's consolidated revenue growth, on typical Duke terms

Β· Fabrikat has a long history of steady turnover and profitability, providing street lighting columns, guardrails and more bespoke products to local councils around the UK via contractors and Original Equipment Manufacturers ("OEMs")

Β· Duke's investment will facilitate a management buyout ("MBO") of two shareholders who, in recent years, have handed over the day to day running of the business to the current management team which has a combined tenure in the business of more than 60 years and lead all aspects of Fabrikat's operations

Β· As part of the recapitalisation, Duke will receive a 30% equity stake in the business

Β 

Neil Johnson, CEO of Duke Royalty, said:

Β 

"Fabrikat is a well-managed business with a longstanding track record of profitability, making it an ideal royalty partner for Duke. The business' long history of growing market share and its ability to withstand and successfully navigate challenging environments, including the recent turbulence created by the pandemic, makes us confident of the Company's short and long-term future prospects. Our support of this MBO reflects our confidence in the management team's ability to continue the success achieved to date and illustrates how effective our capital is in MBO situations.

Β 

"Additionally, with Duke's existing credit facility with Pollen Street Capital, we are well positioned to make more investments in the coming months as we focus on capitalising on the increasing demand for long term, flexible sources of finance."

Β 

Paul Allen, CFO of Fabrikat, said:

Β 

"Duke's investment solution has been a great fit for this transaction. By taking on Duke's capital, the other members of the MBO team and I can assume operational control and a majority equity shareholding in a company where we have worked for most of our careers. We are excited to take Fabrikat forward and build on the excellent reputation of the firm."

Β 

Further information regarding Fabrikat

Fabrikat was founded in 1985 and is now the largest independently owned manufacturer of lighting columns and guardrails in the UK. Fabrikat designs, manufactures and supplies street lighting columns, traffic management and telecommunication structures, pedestrian guardrail, parapet, fencing and street furniture products. Leveraging its decades of experience and expertise in manufacturing and engineering, it has broadened its offering to include column testing, evaluation and asset management services.

Fabrikat has a diverse and expanding customer base, supplying local authorities, contractors, developers, specifiers, wholesalers, and lighting OEMs. Increasingly it is pivoting into higher margin, bespoke sub-sectors.

Two members of the MBO Team have been at the company for more than 30 years and across the management team there is deep technical expertise in the steel fabrication market. The company is based in Sutton-in-Ashfield, UK and employs c.80 staff across its production and administrative functions.

About the Financing

Β 

Duke has committed Β£6.2 million of capital to enable the current management team to shape the future growth and build on the stable foundations of a long-standing, profitable business. Importantly, there will be no change to the day-to-day management of Fabrikat.

Β 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a combination of a secured loan and preference shares and Duke will be entitled to monthly distributions (the "Distribution") beginning in March 2021.

Β 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in total combined gross revenues of the Group for the 12 months to 31 December 2021, compared to the prior financial (calendar) year. The first adjustment will occur from March 2022. The annual adjustment in the Distribution will be subject to an agreed collar.

Β 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Fabrikat utilises an early buyback option which will trigger an early redemption payment to Duke. In addition, Duke has received 30% of the fully diluted ordinary equity of the Group as part of its investment.

Duke Royalty Portfolio

A full list of Duke's current Royalty Partners are now included for reference on our Partners page of our website: www.dukeroyalty.com/partners

Β 

Β 

***ENDS***

Β 

For further information, please visit www.dukeroyalty.comΒ or contact:

Β 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

Β 

Β 

+44 (0) 1481 741 240

Cenkos Securities plcΒ 

(Nominated Adviser

and Joint Broker)

Β 

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

Β 

+44 (0) 207 397 8900

Β 

Canaccord Genuity

(Joint Broker)

Β 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/ Tom Carnegie/ Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

Β 

About Duke Royalty

Β 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses inΒ EuropeΒ and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered inΒ Guernsey.

Β 

Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon publication of this announcement, this inside information is now considered to be in the public domain.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGREAXASFSKFEFA
Date   Source Headline
20th Mar 20179:35 amRNSSch 1 Update - Duke Royalty Limited
17th Mar 20176:17 pmRNSResult of Fundraising
16th Mar 20175:03 pmRNSProposed Placing and Subscription
21st Feb 201711:25 amRNSSch 1 Update - Duke Royalty Limited
1st Feb 201711:00 amRNSSchedule 1 - Duke Royalty Limited
11th Jan 20177:01 amRNSAppointment of Chief Investment Officer
11th Jan 20177:00 amRNSChange of Advisors and Operational Update
17th Nov 20169:00 amRNSUnaudited interim results
1st Sep 201612:02 pmRNSResult of AGM
25th Jul 20167:00 amRNSFinal Results
29th Mar 20161:32 pmRNSSale of investments
7th Mar 20167:00 amRNSBoard Changes and Corporate Update
3rd Feb 20167:00 amRNSDirector/PDMR Shareholding
19th Jan 20169:55 amRNSChange of Adviser
14th Dec 201511:40 amRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim results
29th Oct 20157:00 amRNSHolding(s) in Company
29th Oct 20157:00 amRNSCorrection: Appointment and Issue of Shares
28th Oct 20157:00 amRNSMr Justin Cochrane Appointment and Issue of Shares
12th Oct 20155:16 pmRNSHolding(s) in Company
17th Sep 20153:40 pmRNSFormation of Healthcare Investment Committee
14th Sep 201512:41 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSDirector share purchase
10th Sep 201512:00 pmRNSResult of AGM
7th Sep 20159:15 amRNSGrant of options
7th Sep 20157:00 amRNSPlacing
7th Sep 20157:00 amRNSCollaboration with Oliver Wyman
4th Aug 201512:21 pmRNSChanges to NAV Reporting
27th Jul 20154:12 pmRNSResults for the year ended 31 March 2015
16th Jun 201511:36 amRNSResult of EGM
10th Jun 201511:21 amRNSHolding(s) in Company
2nd Jun 20151:57 pmRNSHolding(s) in Company
28th May 201511:00 amRNSEGM, proposed changes to board & investing policy
26th May 20159:58 amRNSHolding(s) in Company
26th May 20159:57 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
22nd May 20155:15 pmRNSRepayment of zero dividend preference shares
20th May 20157:00 amRNSPlacing
15th May 201511:08 amRNSSale of investment
20th Apr 20155:36 pmRNSNet Asset Value(s)
19th Jan 20154:27 pmRNSNet Asset Value(s)
30th Dec 20143:07 pmRNSInterim Results
9th Dec 20145:23 pmRNSNet Asset Value
3rd Nov 20147:00 amRNSChange of administrator and registered address
22nd Oct 20147:00 amRNSNet Asset Value(s)
20th Aug 20141:54 pmRNSResult of AGM
24th Jul 20147:00 amRNSNet Asset Value(s)
16th Jul 201410:11 amRNSHolding(s) in Company
15th Jul 20147:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.